ESTA (Establishment Labs Holdings) ROCE % : -20.55% (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Establishment Labs Holdings's annualized ROCE % for the quarter that ended in Mar. 2025 was -20.55%.

Establishment Labs Holdings ROCE % Historical Data

The historical data trend for Establishment Labs Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings ROCE % Chart

Establishment Labs Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-25.60

-25.74

-43.66

-32.95

-26.04

Establishment Labs Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															-19.57	-18.62	-18.27	-46.97	-20.55

Establishment Labs Holdings ROCE % Calculation

Establishment Labs Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-63.799	/	( ( (268.641 - 57.15)	+	(346.831 - 68.278) )	/ 2 )
	=	-63.799	/	( (211.491	+	278.553)	/ 2 )
	=	-63.799	/	245.022
	=	-26.04 %

Establishment Labs Holdings's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	-55.772	/	( ( (346.831 - 68.278)	+	(333.364 - 69.038) )	/ 2 )
	=	-55.772	/	( ( 278.553	+	264.326 )	/ 2 )
	=	-55.772	/	271.4395
	=	-20.55 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Establishment Labs Holdings (NAS:ESTA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Establishment Labs Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Establishment Labs Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (NAS:ESTA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

3E0:Germany

Address

Coyol Free Zone, Building B15 and 25, Alajuela, CRI

Website

https://establishmentlabs.com

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Executives

Jw Asset Management, Llc	10 percent owner, other: See Footnote(1)	1051 N VENETIAN DRIVE, MIAMI BEACH FL 33139
Chacon Quiros Juan Jose	director, officer: Chief Executive Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Nicholas Sheridan Lewin	director, 10 percent owner	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Raj Denhoy	officer: Chief Financial Officer	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Dennis E Condon	director	811 ALSTON RD, SANTA BARBARA CA 93108
Leslie Gillin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Paul D. Rodio	officer: Chief Operating Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Samuel Ross Mansbach	other: GC & Chief Compliance Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Bryan Slotkin	director	C/O MOTIVA USA,.LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Ann Custin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Edward J Schutter	director	C/O FIRST HORIZON PHARMACEUTICAL CORP, 6195 SHILOH ROAD, ALPHARETTA GA 30005
Lisa Gersh	director	C/O HASBRO, INC., 1011 NEWPORT AVENUE, PAWTUCKET RI 02861
Mezerville Roberto De	officer: Chief Technology Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Renee Gaeta	officer: Chief Financial Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Pratip Dastidar	officer: Head of Global Operations	150 PEABODY PLACE, MEMPHIS TN 38103